ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,659Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 70

$520K Total Retail Price of All Prescriptions

Rank: 22 out of 70

494 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 494 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

5% of this provider’s 494 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 8,302 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LEVOTHYROXINE SODIUM 359 347 1 2
SIMVASTATIN 304 290 2 1
LISINOPRIL 278 274 3 3
WARFARIN SODIUM 259 256 4 10
AMLODIPINE BESYLATE 255 253 5 5
METOPROLOL TARTRATE 207 197 6 7
FUROSEMIDE 204 201 7 6
DONEPEZIL HCL 203 192 8 11
SERTRALINE HCL 158 158 9 22
TRAMADOL HCL 145 145 10 17
NAMENDA 143 143 11 13
HYDROCHLOROTHIAZIDE 134 126 12 15
OMEPRAZOLE 131 118 13 4
TAMSULOSIN HCL 130 124 14 29
MIRTAZAPINE 126 126 15 20
POTASSIUM CHLORIDE 114 113 16 12
CARVEDILOL 108 99 17 19
DIOVAN 105 102 18 44
ALENDRONATE SODIUM 102 100 19 28
METFORMIN HCL 93 82 20 9
PANTOPRAZOLE SODIUM 93 93 20 42
ATORVASTATIN CALCIUM 83 75 22 27
GABAPENTIN 80 80 23 14
RAMIPRIL 79 76 24 125
ZOLPIDEM TARTRATE 75 70 25 23
METOPROLOL SUCCINATE 74 74 26 25
CLOPIDOGREL 70 70 27 30
DIGOXIN 70 70 27 41
TRAZODONE HCL 68 68 29 36
ALLOPURINOL 61 56 30 31
FAMOTIDINE 61 59 30 73
HYDROCODONE-ACETAMINOPHEN 61 59 S3 30 8
AZITHROMYCIN 55 50 33 40
LEVOFLOXACIN 55 55 33 71
ATENOLOL 54 50 35 21
PLAVIX 54 54 35 43
CRESTOR 54 54 35 45
PREDNISONE 53 52 38 52
CITALOPRAM HBR 53 53 38 16
LOSARTAN POTASSIUM 52 51 40 24
DIVALPROEX SODIUM 52 41 40 53
BUMETANIDE 50 41 42 109
ESCITALOPRAM OXALATE 50 50 42 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.